The latest news and developments related to extracorporeal CO2 removal and the Hemolung RAS.
The Hemolung RAS has won the Gold Award in the Critical-Care and Emergency Medicine Category of the 17th Annual Medical Design Excellence Awards (MDEA) competition. The announcement was recently made during a ceremony at the MD&M East conference in New York.
This user report by Dr. Susanne Ilkjær describes the case of a patient who had received a lung transplant over a year prior to undergoing the surgical repair of a broken femur. Subsequent to the surgery, the patient was unable to be extubated and became hypercapnic despite maximal ventilatory support at high peak airway pressures. Extracorporeal CO2 removal (ECCO2R) with the Hemolung Respiratory Assist System (RAS) was successfully utilized to enable reductions in peak ventilator airway pressures and normalization of arterial pH and CO2 tension.
Initial Australian Experience with the Hemolung RAS presented at EURO-ELSO
Dr. Hergen Buscher of St. Vincent’s Hospital (Sydney, Australia) recently presented the initial Australian Hemolung RAS experience at the EURO-ELSO 2014 conference in Paris. In his report, three COPD patients suffering acute exacerbations and deemed to be at a high risk of being intubated were successfully treated with the Hemolung RAS.
In this case report, a 47 year old female with severe COPD awaiting lung transplant was admitted to the ICU with an acute exacerbation requiring noninvasive ventilatory support. Almost immediately her condition deteriorated and avoiding intubation and invasive mechanical ventilation became vital to maintaining her status on the transplant list. Through ECCO2R with the Hemolung RAS, she avoided intubation and remains on the transplant list 3 months after her exacerbation.